SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Dong-A ST Wins South Korean Approval for Type 2 Diabetes Combination Drug

Dong-A ST secured South Korean approval for a combination drug to treat Type 2 diabetes.

Related stories